FluoroPharma Medical, Inc. (FPMI)

Market Cap	5.52K
Revenue (ttm)	n/a
Net Income (ttm)	-2.57M
Shares Out	27.58M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,600
Average Volume	96,498
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0000 - 0.0002
Beta	-118.54
RSI	44.78
Earnings Date	n/a

About FluoroPharma Medical

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in pati...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: FPMI